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a b s t r a c t
Purpose: Approximately one-third of children with epilepsy have clinical syndromes characterized by
drug resistance. Modified Atkins dietary therapy (MADT) can reduce seizures and improve health outcomes for these children. This intervention is yet to be consistently offered as standard of care in subSaharan Africa.
Objectives: This study aimed to assess feasibility and acceptability of MADT for children with drugresistant epilepsy and identify enabling strategies for implementation and adherence to the MADT.
Methods: This qualitative inquiry utilized in-depth interviews with purposively selected caregivers and
adolescent patients having used MADT for drug-resistant epilepsy. A qualified team consisting of a social
scientist and an interviewer carried out the interviews with consenting participants. Thematic analysis
was done independent of the clinicians.
Results: This study enrolled 17 participants including 14 caregivers of children aged 1–17 years, and
three adolescents. Caregivers were predominantly trained professionals living in urban areas who had
attended the epilepsy clinic for at least one year. Duration of continuous MADT use ranged from two
weeks to two years. Among participants who indicated that they could afford to provide the MADT, it
was less costly to provide for younger children and for those living in rural areas. At the time of the study,
majority of the caregivers had ceased administration of the MADT, more than half of whom reported barriers including cost of food, child refusal of foods, and inconsistent dietician support. Social support was a
key enabler to successful implementation and continuation of the diet. Majority of the participants considered MADT to be an effective and acceptable intervention for management of epilepsy.
Conclusions: Among participants in this focused Kenyan group, implementation of MADT was found to be
feasible particularly for younger children living in rural areas. Majority of participants evaluated MADT to
be an effective and acceptable intervention for management of epilepsy. Cultural factors did not influence
feasibility or acceptability of MADT in this study.
Ó 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Abbreviations: AKUH-N, Aga Khan University Hospital Nairobi; ASM, Anti-seizure medications; CG, Caregiver; ICF, Informed Consent Form; IDI, In-depth Interview; KES,
Kenyan shillings; LMIC, Low- and middle-income countries; MADT, Modified Atkins diet therapy.
⇑ Corresponding author at: Aga Khan University, East Africa, 3rd Parklands Avenue, East Tower Block, Fourth floor, P.O BOX 30270, 00100 Nairobi, Kenya.
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https://doi.org/10.1016/j.yebeh.2021.108362
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1. Introduction

2. Material and methods

An estimated one-third of children with epilepsy have clinical
syndromes characterized by drug resistance, necessitating palliative interventions [1–3]. Global evidence indicates that dietary
therapies are efficacious when offered to children with drug-resistant epilepsy, with reduction in the number of seizures, reduction
in hyperactivity, and improvement in cognition reported [4]. The
modified Atkins diet is a more relaxed diet to implement in comparison to the classical or medium chain triglyceride Atkins diet
[5–7]. Although low carbohydrate, the allowance of unlimited protein improves palatability thus enhancing compliance. The modified Atkins diet has been effectively used to treat drug-resistant
epilepsy in both children and adults [5,6]. The efficacy of modified
Atkins diet therapy (MADT) at three and six months postimplementation has proven to be successful with over 50% of
patients achieving greater than 50% reduction in seizure frequency
[7,8]. One study found that the most effective seizure control
approach was using a ‘‘patient-tailored diet” where families
worked independently to find the most appropriate level of fat
intake and ketosis for their child’s therapy [5]. This resulted in over
90% seizure freedom and resulted in better compliance [5]. The
MADT has gained popularity in some resource-constrained settings
due to its flexibility allowing adaptation into local diets [9]. However, implementation of this efficacious non-pharmacologic intervention has lagged behind in sub-Saharan Africa compared to
other parts of the world [10].
The burden of epilepsy is significantly higher in low- and
middle-income countries (LMIC) partly because of a preponderance of infectious diseases as well as occurrence of multiple potentially preventable causes including perinatal events and head
trauma [11]. In 2016, an estimated 45.9 million people with active
epilepsy; whose peak prevalence was 5–9 years of age lived in
LMIC [12]. The prevalence of active convulsive epilepsy in children
aged below 9 years ranged from 2 per 1000 to 12 per 1000 [13–15].
Drug-resistant epilepsy portends a poor outcome for patients due
to associated premature mortality, various comorbidities, social
implications and an overall poorer quality of life [1,3,16]. These
observations make it imperative that feasible palliative care treatments such as MADT are urgently implemented in regions with the
greatest burden of children with drug-resistant epilepsy.
The epilepsy treatment gap is documented to exceed 80% in
some rural areas of Kenya due to stigma, lack of public awareness,
unavailability of appropriate anti-seizure medications, and financial incapacity that hampers access to health services [17,18].
Utilization of dietary therapies, including MADT, has been proposed as an intervention to aid in the closure of the epilepsy treatment gap [9,10,19]. Acceptability of MADT in various settings has
been linked to healthcare worker support to mitigate against factors such as illiteracy and distance, flexibility in allowing slower
reduction of the carbohydrate portions, use of patient support
groups, and utilization of available local foods in the implementation of MADT [20–24]. There are minimal data available on utilization of dietary therapies for children with drug-resistant epilepsy
in Sub-Saharan Africa. Despite the undisputed efficacy of dietary
therapies in other parts of the world, barriers to widespread implementation in sub-Saharan Africa remain unknown. This study
sought to explore caregiver’s and adolescent’s experience with
the MADT; and potential enabling factors which could be harnessed to facilitate scalability of this therapy.

2.1. Study design and participants
This qualitative study employed in-depth interviews (IDI) and
was conducted between August and September 2020. A qualified
team, including a senior social scientist and one research assistant
carried out the interviews independent of the clinical practitioners.
The research assistant was competitively recruited on the basis of
the level of education, with demonstrated IDI facilitation and note
taking experience. A two-day training was conducted with a focus
on introduction to the study, research ethics, data collection methods, study tools, data management, the consent and assent process,
and documentation.
The dialog centered around MADT intervention that had been
offered to patients at the Aga Khan University Hospital in Nairobi
(AKUH-N). The study sought to assess the feasibility and acceptability of MADT for children with drug-resistant epilepsy, and their
caregivers. Fig. 1 provides a summary of the diet as recommended
at the Aga Khan University Hospital, Nairobi.
A qualified dietician scheduled an appointment for each family
to introduce the MADT and provide guidance on quantities of foods
to be used, types of foods that were most suitable, and those to be
avoided. The session also included information on where to obtain
the foods locally and sample recipes were provided. Caregivers
were informed that the aim of the dietary changes was to ensure
no more than 20 g of carbohydrates were to be consumed on any
given day and that the main source of energy would be provided
by fats. The child was allowed as much protein as they needed
for growth which was typically 35% of the total calorie intake
and were to consume adequate amounts of water (4–6 glasses
per day). Regular meals in 4–5 portions for children younger than
three years and 3–4 meals for those older than three years as well
as daily exercise or occupational therapy three times per week as
were recommended. Families were informed that constipation,
dehydration, and vomiting as well as feeling sluggish during the
initial days were potential side effects and measures to avoid and
manage these unwanted effects were discussed. These measures
included increasing the oral water intake, and in severe cases
where the child was not able to retain food due to vomiting they
were asked to report to the emergency room at AKUH, N. Addition
of water, berries, whole grains, and exercise was advised to help
manage constipation and if this persisted, patients were referred
for review by the pediatrician. Reviews with the dietician were
scheduled initially after two weeks, then after every three months.
Calcium and vitamin supplements were prescribed to mitigate
against potential nutritional deficiencies while on a highly
restricted diet [25].
The study was conducted at the AKUH-N pediatric neurology
clinic in Nairobi. Eligible study participants were primary caregivers of children aged 2–17 years with drug-resistant epilepsy
as per ILAE recommendations [25], who were on MADT, or had utilized MADT in the preceding 10 years; who were able and willing
to provide written informed consent to participate in the study;
and children above 8 years of age who had undertaken MADT previously and were able to provide assent for the study and were able
to participate in an IDI. In qualitative studies, saturation is the
point at which no new data are obtained on evaluation of the interview record and is commonly used to determine the sample size.
Previous reviews have indicated that minimal additional data are
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Useful measurements
1 cup = 250ml volume
1 fruit = 1 cup fruit salad
½ cup cooked vegetables = 1 cup raw
vegetable
Foods allowed:
1. Meat products: Beef,
chicken, pork, lamb, liver, and
sea foods
2. Select fruits: Avocado,
strawberries, guava,
watermelon, cantaloupe, lemon
3. Fats: Margarine, vegetable
oils, buer, cow and coconut
milk and cream, mayonnaise.
4. All vegetables except starchy
vegetables eg potato, arrow
root, wheat, rice, corn, banana
5. Eggs

Modified
Atkins Diet

Foods to be avoided:
1. Starch: Arrowroots, cassava,
bananas, rice, pasta, sweet
potatoes, irish potatos, wheat
and corn breads, breakfast
cererals (e.g. weetabix and
cornﬂakes)
2. Select milk products: Fresh
milk, ice cream, yoghurt
3. All other fruits

Useful ps and reminders:
-Remove skin from chicken and use lean
meats
-Avoid sugar and foods with added sugar
-Eat wholesome and natural foods
-Drink 4-6 glasses of water daily
-Exercise or play daily for 1-2 hours or have
occupaonal therapy thrice a week
-Avoid skipping meals
-Add extra liquid oil to food

Fig. 1. The Modified Atkins Dietary therapy (MADT) applied at the Aga Khan University Hospital, Nairobi.

rarely obtained by interviewing greater than 20 individuals for a
specific category of participants [26,27]. Hence, this study aimed
to purposively select 20 participants to include 15 caregivers and
5 children with drug-resistant epilepsy. All tools utilized during
the IDI are provided in Appendix 1.

Socio-demographic data were collected including caregiver’s
age, gender, profession, income, education, marital status, and residence. Information on duration of epilepsy clinic attendance,
duration of child’s epilepsy diagnosis, and duration of MADT use
was also documented.

2.2. Recruitment and data collection

2.3. Ethical considerations

Participants were identified from the medical records of the
AKUH-N pediatric neurology clinic and invited to participate in
the study. Primary caregivers were contacted by telephone prior
to a regular hospital clinic visit and informed of the study. During
the next regular clinic visit, the research assistant engaged caregivers again and explained the study in full. Caregivers who gave
consent to participate in the study were invited for the IDIs at
AKUH-N at a date convenient to the care giver within the following
two weeks. Transport was reimbursed for the second visit.
The semi-structured IDI guide captured details on the length of
time the diet was undertaken for, food components that were utilized, effect of the diet on seizure frequency, cost of the diet to the
family, and adverse effects and challenges encountered. The IDI
guide also included preparedness of the family to undertake the
diet, their understanding of MADT, their expectations regarding
outcomes, enabling factors, and challenges encountered during
implementation of the diet. The interview guide included openended questions initially, then more focused probes were
employed in the latter part of the interview process.

Prior to any data collection event, consent (and assent as appropriate) was obtained. Appendix 2 provides the document utilized
in this process. For minors, a standardized assent document was
used to ensure they understood and were fully willing to participate in the IDI. Consent documents were available in English which
all caregivers were conversant with and each participant signed
two copies. Kiswahili translations of the consent documents were
also available. One copy of the signed form was given to the study
participant while the study team stored the second copy. For the
verbal assent, the RA documented and signed all forms to confirm
that the minor had been informed and that they had agreed to participate in the study. All signed copies of consent and assent forms
were stored in a locked cabinet at the end of each data collection
session. The social scientist monitored the progress of protocol
implementation to ascertain all safety, consent, and assent regulations were being observed. Interviews were administered in English and lasted 20 min on average for adolescents and 35 min for
the caregivers. Sessions were undertaken at a quiet and private
office at the AKUH-N. Adolescents were interviewed in the absence
3
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help a family successfully implement MADT, caregivers expressed
the need for support from other caregivers who had utilized the
therapy and considered this just as important as professional dietician support.
Five caregivers elaborated on strategies which enabled them
adhere to the MADT including; avoidance of social gatherings,
informing friends and family of the child’s needs and providing
packed food for the child to carry with them to school and social
events. Majority of the caregivers reported having to make changes
to their shopping patterns due to restrictions on choices of food
that could be utilized, MADT cost-related challenges and time
taken to prepare meals for the family. Some caregivers blended
and mashed the food to ensure the child would find it palatable.
The most illustrative quotes on feasibility of MADT are provided
in Table 1.

of their parents. This study was guided by a protocol approved by
the Aga Khan University (AKU) Institutional Ethics Review Committee (no. 2020/IERC-93(v2)). Additional permission to conduct
the study with adherence to institutional COVID prevention policies and from the National Commission for Science, Technology
and Innovation (NACOSTI) was sought and granted. Measures to
prevent transmission of Coronavirus Virus Disease 19 (COVID 19)
including consistent use of masks and hand sanitization were
implemented during data collection. Confidentiality of study participant data was ensured throughout the study.
2.4. Data analysis
Following completion of interviews and transcription of
recorded data, all transcripts were analyzed using NVivo 12 software. The study followed phases of thematic analysis as described
by Braun and Clarke [28]. Three coders familiarized themselves
with the data and generated initial codes across the data set. They
coded all the transcripts and consequently searched for themes by
collating identified codes and gathering data that were relevant to
each theme. They then reviewed, defined and named all themes,
and produced an analysis report. Appropriate vivid quotes were
used to support described themes.

3.3. Acceptability of MADT intervention
Twelve caregivers felt that MADT was an appropriate and safe
intervention for management of epilepsy in children, with five of
them indicating that they preferred MADT over medication. Majority said they were satisfied with the MADT, despite observed negative effects such as constipation and weight loss. Reduction in
hyperactivity and improved stability on walking were functional
improvements linked to positive evaluations of MADT. One caregiver expressed that persistence in providing the diet eventually
led to the child’s acceptance of MADT.
All adolescent participants were aged between 12 and 17 years
of age, and had all encountered challenges while undertaking the
MADT. They described avoiding foods prescribed for MADT that
they did not like, the inconvenience of having to carry snacks from
home to school, or having a home meal delivered to school. Adolescents reported benefits of the MADT in terms of seizure control,
reduction in body weight, and improved vitality which motivated
them to continue the therapy. One child was still using the MADT
at the time of the study. Two adolescents reported satisfaction
with MADT and considered the intervention to be appropriate for
management of epilepsy in other children. The most illustrative
quotes on acceptability of MADT are provided in Table 2.

3. Results
3.1. Demographic findings
This study successfully engaged 17 participants including 14
caregivers and three adolescents with drug-resistant epilepsy.
One male and 13 female caregivers were interviewed. All caregivers reported tertiary-level education except one who attained
secondary school level education. Caregivers’ age ranged from 19
to 40 years, eleven of them were married, and all were involved
in diverse occupations. Thirteen caregivers lived in urban areas
and one in a rural area. Duration of their child’s epilepsy diagnosis
and clinic attendance ranged from 1 to 14 years, while the duration
of MADT use ranged from 2 weeks to 24 months. At the time of the
study only three caregivers were still administering the MADT.
Seven caregivers earned more than 100,000 Kenya shillings per
month while ten caregivers earned between 50 and 100,000 Kenya
shillings per month. (1 USD = 108 Kenya shillings.)

4. Discussion
3.2. Feasibility of the MADT
This qualitative study highlights the experience of caregivers
and adolescents who utilized MADT as part of management for
drug-resistant epilepsy. There are minimal data from subSaharan Africa on this topic and knowledge gained from this study
serves to provide insights on this under-explored subject. Indeed,
recommendations that dietary therapies should be provided for
children living with drug-resistant epilepsy in LMIC settings have
been made [10,29–31], and guidelines provided [25,32]. However,
implementation of ketogenic therapies for management of epilepsy as standard of care in Kenya remains largely in abeyance.
Despite the development of newer medications in recent years,
approximately one-third of all appropriately treated patients with
epilepsy continue to have active epileptic seizures [33]. A large
treatment gap for epilepsy has been described in Kenya specifically, which further contributes to the local burden of the disease
[17,18]. Scale-up of utilization of Ketogenic dietary therapies in
the country would contribute to reduction of the epilepsy treatment gap and would be more sustainable than access to newer
and more expensive anti-seizure medications or other interventions such as epilepsy surgery and vagal nerve stimulation for
which the infrastructure has yet to be created.

Six caregivers indicated financial ability to provide the MADT.
One participant reported that it was easy to implement the diet
for her child because he was only two years old, hence the diet
was more affordable while another caregiver who lived in a rural
area found the MADT affordable. Four caregivers who had to purchase most of the food supplies from supermarkets found the
MADT costly and estimated that 5000 to 10,000 Kenya shillings
(46–93USD) was required over and above their regular budget
each month. All caregivers indicated that foods required to implement the MADT were available in local shops and markets.
Ten caregivers who continued the MADT for at least six months
indicated that support from extended family and their spouses was
very important in enabling them implement the MADT. Three caregivers felt they could not cope with the diet without additional
support; one was single and the other two had a spouse who
was not engaged in the implementation of MADT. Caregivers also
considered dietician support as key in enabling them adhere to
meal plans that had been provided at the initial consult. Lack of
familiarity with the MADT was one of the reasons these sentiments
came to the fore. When asked what other support could potentially
4
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Table 1
Feasibility of MADT in Kenya.
Theme

Sub theme

Illustrative quote

Availability of foods

‘‘The availability of the food. . . I think if you have money then the food is there. You can easily get it.” (CG 7)
‘‘It was a bit of a challenge but I must admit that I stood up to the challenge because availability of the foods, cost factors, even the
preparations required extra effort. But I made sure that I stood up to the challenge, I did well.” (CG 13)
‘‘I am not very sure of the total cost. . . but the local food is available it is relatively cheap. The price. . .I think it is affordable, I
think it is affordable” (CG 2)
‘‘Yeah! Considering that by the time he was starting the diet he had just clocked 2 years. So, feeding a 2-year child is not as
expensive as feeding a full-grown adult. Yeah.” (CG 12)
‘‘I believe that if there was a way professionals could find a way of reaching out to those who live in rural areas, it would be good.
I believe it would be cheaper for those living there, cheaper than buying medicine, because if one finds out a certain kind of food
that works for them, especially in their local market, the diet could work for them.” (CG 3)
‘‘I used it [the MADT] for a short time. I cannot say that I am okay with it because it is a bit pricey getting these foods from the
supermarket, unless there is an option of foods that I can afford. . . but for now, it is something that I am not able to do.” (CG 1)
‘‘Because of my child’s condition, family knew that he had a special diet. Every time we would go visiting, they would call and ask
what they should prepare for him. I would say they were very supportive and you would never find them trying to sneak him
sweet things because they understand. So, even when they are out there, they are very cautious. They know what he is supposed
to eat. They are very supportive. (CG 3)
‘‘He was the sole provider. His Dad provided everything and he would also help feeding him when it was very difficult. Sometimes,
the baby became irritable and he would assist in feeding the child. I remember that the child would wake up at night and his dad
would have only three or four hours of sleep” (CG 8)
‘‘At first it was difficult because there was no support from my husband. It was quite difficult, so I was trying on my own but it
reached a point, it was so impossible. I gave up. Yeah” (CG 5)
‘‘. . . I think we just attended the session with the dietician once and you see now this is a journey, it is a struggle you need
somebody who is backing you up and every now and then if you want to ask a question you need to have someone who is there
for you . . .” (CG 10)
‘‘It was not very easy to follow and was new to us. Given that we were told some protein sources like beans had traces of
carbohydrates. . .It means that it was not easy to do it because you had to be so cautious. That is why that diet would be easier
when it’s done when you are working hand in hand with a dietician properly. . .a dietician who understands and will advise you
on the process.” (CG 14)
‘‘I feel like a dietician would be advising you based on what they have learnt and what the book says and all that; which is okay.
But I also feel that if they engage someone who has been there. . .has used the diet. . . someone who is walking in the same shoes,
it would be better.” (CG 3)
‘‘I would always pack her food. When she would go to school, I would pack her meals. So, she never ate anything apart from what
I prepared at home.” (CG 13)
‘‘Ooh! So, number one there is no social event that he attends. There are no birthdays, yeah. There is no going out. There is no. . .
like zero. Simply because we don’t want to introduce him to certain environments. Places that he sees other kids eating stuff that
he can’t eat. So, basically that’s the reason why we don’t take him out. But he will interact with kids in the court and play with
them, so long as someone is there watching him. Yeah, so we leave no room to chance (laughs). . . (CG 12)

Feasibility of
MADT

Cost of MADT

Family support

Dietician support & Peer
support

Adaptations to enhance
compliance

to availability of prescribed food options required to implement
the MADT in the local Kenyan setting and hence the possibility
of widespread adoption of this therapy in the country.
More than half of the caregivers were able to adhere to MADT
for extended periods of time. Enabling factors which should be harnessed in future implementation of MADT include; enlisting
extended family support and establishment of support groups that
include families whose children are on dietary therapies for the
management of epilepsy. Parent support groups as key factors in
determining the success of MADT implementation have been cited
in studies by El Rashidy and Park [22,40].
Poor availability of dietician support was cited as one of the factors that posed a significant challenge for continuation of MADT.
Previous studies have demonstrated that dieticians are key for
the implementation of Atkins diets for the management of epilepsy
[41]. Kossoff et al proposed that dietician support was not mandatory for other forms of ketogenic dietary therapies apart from classic ketogenic diet in low resource areas [19]. Findings from this
study suggest otherwise and indeed it appears to be important that
future studies examine dietician’s attitudes and training as well as
their capacity to support families utilize MADT particularly in low
resource areas.
Despite the high level of education reported in this cohort of
caregivers, this study highlights challenges encountered in following dietician instructions which could have contributed to some of
the frustrations they experienced such as weight gain and suboptimal efficacy of the MADT. This calls for careful counseling at

4.1. Feasibility of MADT
It is encouraging to note that majority of caregivers considered
MADT a feasible option for their child with epilepsy. Availing
MADT for younger children was less challenging compared to older
children because required dietary changes were easier to implement and the cost of associated dietary changes was lower. Miranda and others have reported the ease with which ketogenic
diets have been instituted in younger infants with drug-resistant
epilepsy as well as the greater efficacy observed from this intervention in younger children [5,34,35]. These observations have
been attributed to the commencement of dietary therapies earlier
on in the disease process, better compliance with dietary changes
in younger children, and possibly also biological factors including
state of metabolism in this age group [34,35].
An interesting enabler highlighted in this study was the fact
that required dietary changes were cheaper to implement in rural
areas because requisite food items were cheaper in that setting.
Caregivers strongly felt that the cost of the diet was location
related as food costs are significantly lower in the rural areas.
Majority of the Kenyan population still live in the rural areas
[36], hence scale-up of MADT in the country is feasible particularly
in rural areas where majority of children with epilepsy reside.
Diets in many countries in sub-Saharan Africa are predominantly starch based [37–39], a factor which may cause concern
regarding availability of food options required to implement the
MADT; hence it was reassuring to note that caregivers attested
5
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[22,24,42]. In this study, satisfaction with the MADT was closely
related to how effective the intervention was in reduction of seizures. Probably due to the cosmopolitan nature of diets engaged
in by the study group, cultural factors and food preferences were
not a hindrance to the uptake of MADT for this cohort of
participants.
Consciously planning services to allow for appropriate levels of
dietician support is a surmountable barrier which could further
improve feasibility and acceptability of MADT in Kenya. This can
be achieved by ensuring appropriate training in ketogenic dietary
therapies in dietician curricula, refresher education of dieticians
post training to improve confidence in application, and also lobbying for government and institutional support to avail dieticians
familiar with MADT at centers where patients with complex epilepsy are referred.

Table 2
Acceptability of MADT in Kenya.
Theme

Sub theme

Illustrative quote

Acceptability
of MADT

Preference over
medications

‘‘I would prefer a diet instead of just having
some medication. I think if it really worked
then I would prefer going that route instead
of having a bunch of medications for the
baby.” (CG 1)
‘‘It was like the last beam of hope I would
say for our baby for the seizures. So that
was the initial motivating factor. And after
that, it was because of the improvements
that we were seeing with his condition. I
think that’s the reason why we still do it
and we will probably do it for the next two
years until something changes.” (CG 12)
‘‘To me, I think it [MADT] is appropriate. If
we can do away with medicine and have a
diet that works, the better”. (CG5)
‘‘As I said, I saw a marked change in the
seizure activity. They reduced considerably.
That motivated me, it kept me going and I
could see it had a positive benefit for her.”
(CG 13)
‘‘Yeah! Actually all my expectations were
met. So, we are currently going on
3 months (phone rings) convulsion free.
Yeah, so they were all met.” (CG 12)
‘‘He doesn’t get many seizures like before. . .
he used to get up to 10 per day. When he
wakes up, when he is walking. . . they were
very many! But right now we have reduced
them to waking up seizures. But with the
diet it is really helping. I am like 90%
satisfied. The 10% challenge is during visits.
Like when you go for safaris and holidays,
you can’t easily get all that you need.
Everything is coated with wheat, at home
you can ensure that you don’t use wheat in
coating your food. . .” (CG 8)
‘‘At first it was difficult, but I said, as I
continued doing it over and over, he
adjusted but it took about three months.
But I would tell that he was not comfortable
adjusting.” (CG 3)
‘‘And how did you feel about the change in
diet? - I felt good, yeah! Yes, the diet was
not hard. Yeah, let me tell you this. Seizures
they don’t come. They don’t come even at
all! Yeah, I am happy off course. The only
thing I get that’s disappointing me, is that I
get headaches and stomach aches. And then
I go and vomit (Adolescent 1)
‘‘It can help people. . . I stopped taking
drugs for my seizures.” (Adolescent 2)
‘‘Yes I was happy with the diet apart from
the coconut oil” (Adolescent 3)

Reduction in
seizures with
MADT

Child’s
acceptance of
MADT

4.3. Limitations of the study
Some of the limitations of this study were that it was performed
in a setting where caregivers were well educated and also better
resourced than majority of Kenyans, and hence the findings may
not be easily generalizable. There were no cultural barriers to the
implementation of MADT elicited in this setting, a factor which
has been cited in several other studies and may be a limiting factor
on large-scale implementation of MADT.

5. Conclusions
Implementation of MADT in in Kenya is feasible particularly for
younger children living in rural areas where food items required
for MADT intervention are cheaper. Both caregivers and adolescents found MADT to be an appropriate and acceptable intervention for management of epilepsy. Dietician, family and social
support, availability of food items required for MADT, and a child’s
acceptance of new foods were important for the successful implementation of MADT. Cultural factors did not influence feasibility or
acceptability of MADT in this study.
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